Research article 11 August 2026

Portuguese macroalgae as a source of bioactive compounds with selective anticancer activity against breast cancer cells

Authors

CC BY 4.0 Published: 11 August 2026 DOI: 10.17305/bb.2026.13870

Abstract

Marine-derived natural products are promising sources of new anticancer agents, but the bioactivity of Portuguese macroalgae and halophytes remains insufficiently explored. This study aimed to identify extracts with selective antiproliferative activity against breast cancer cells using environmentally sustainable extraction methods. Crude extracts were prepared by ultrasound-assisted extraction with water or 10% dimethyl sulfoxide (DMSO) and screened in human MCF-7 breast adenocarcinoma cells using the sulforhodamine B (SRB) assay after 48 h of exposure. Active extracts were subsequently evaluated in non-tumorigenic MCF-12A breast epithelial cells, and half-maximal effective concentrations (EC50) were determined from concentration–response curves. Of 48 crude extracts screened, 21 inhibited MCF-7 cell proliferation in a concentration-dependent manner and were selected for further evaluation. Three extracts derived from the brown macroalgae Bifurcaria bifurcata II and Ericaria selaginoides—two aqueous and one DMSO-based—showed selective activity against MCF-7 cells without detectable inhibition of MCF-12A cells within the corresponding concentration ranges. These findings identify Portuguese macroalgae as promising sources of selectively active anticancer metabolites and support further phytochemical characterization and mechanistic investigation using sustainable bioprospecting approaches.

Keywords

Bioprospection bioactive metabolites phytochemical green extraction anticancer activity marine pharmaceuticals

Downloads

Download data is not yet available.

References

Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299–309. https://doi.org/10.1038/s41586-019-1730-1 DOI: https://doi.org/10.1038/s41586-019-1730-1

Vaidya FU, Chhipa A, Mishra V, Gupta VK, Rawat SG, Kumar A, et al. Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Rep. 2020;5(12). https://doi.org/10.1002/cnr2.1291 DOI: https://doi.org/10.1002/cnr2.1291

Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971;93(9):2325–7. https://doi.org/10.1021/ja00738a045 DOI: https://doi.org/10.1021/ja00738a045

Gutiérrez-Rodríguez AG, Juárez-Portilla C, Olivares-Bañuelos T, Zepeda RC. Anticancer activity of seaweeds. Drug Discov Today. 2018;23(2):434–47. https://doi.org/10.1016/j.drudis.2017.10.019 DOI: https://doi.org/10.1016/j.drudis.2017.10.019

Mohammed HA, Emwas AH, Khan RA. Salt-tolerant plants, halophytes, as renewable natural resources for cancer prevention and treatment: roles of phenolics and flavonoids in immunomodulation and suppression of oxidative stress towards cancer management. Int J Mol Sci. 2023;24(6):5171. https://doi.org/10.3390/ijms24065171 DOI: https://doi.org/10.3390/ijms24065171

Lann KL, Rumin J, Cérantola S, Culioli G, Stiger-Pouvreau V. Spatiotemporal variations of diterpene production in the brown macroalga Bifurcaria bifurcata from the western coasts of Brittany (France). J Appl Phycol. 2014;26(2):1207–14. https://doi.org/10.1007/s10811-013-0148-7 DOI: https://doi.org/10.1007/s10811-013-0148-7

Moussavou G, Kwak D, Obiang-Obonou B, Maranguy C, Dinzouna-Boutamba SD, Lee D, et al. Anticancer effects of different seaweeds on human colon and breast cancers. Mar Drugs. 2014;12(9):4898–911. https://doi.org/10.3390/md12094898 DOI: https://doi.org/10.3390/md12094898

Gálvez M, Martín-Cordero C, López-Lázaro M, Cortés F, Ayuso MJ. Cytotoxic effect of Plantago spp. on cancer cell lines. J Ethnopharmacol. 2003;88(2):125–30. https://doi.org/10.1016/S0378-8741(03)00192-2 DOI: https://doi.org/10.1016/S0378-8741(03)00192-2

Rodrigues M, Gangadhar K, Vizetto-Duarte C, Wubshet S, Nyberg N, Barreira L, et al. Maritime halophyte species from southern Portugal as sources of bioactive molecules. Mar Drugs. 2014;12(4):2228–44. https://doi.org/10.3390/md12042228 DOI: https://doi.org/10.3390/md12042228

Braga MEM, Seabra IJ, Dias AMA, de Sousa HC. Recent trends and perspectives for the extraction of natural products. In: Prado JM, Rostagno MA, editors. Natural product extraction: principles and applications. 2nd ed. Cambridge: Royal Society of Chemistry; 2022. p. 459-543. (Green Chemistry Series; no. 71). https://doi.org/10.1039/9781839165894-00459 DOI: https://doi.org/10.1039/9781839165894-00459

Dias ALB, de Aguiar AC, Rostagno MA. Extraction of natural products using supercritical fluids and pressurized liquids assisted by ultrasound: current status and trends. Ultrason Sonochem. 2021;74:105584. https://doi.org/10.1016/j.ultsonch.2021.105584 DOI: https://doi.org/10.1016/j.ultsonch.2021.105584

Takeuchi TM, Pereira CG, Braga MEM, Maróstica Jr MR, Leal PF, Meireles MAA. Low pressure solvent extraction (solid-liquid extraction, microwave assisted and ultrasound) from condimentary plants. In: Meireles M, editor. Extracting bioactive compounds for food products: theory and applications. Boca Raton: CRC Press; 2009. Chapter 4. p. 464. ISBN: 978-1-4200-6237-3.

Oniszczuk A, Podgórski R. Influence of different extraction methods on the quantification of selected flavonoids and phenolic acids from Tilia cordata inflorescence. Ind Crops Prod. 2015;76:509–14. https://doi.org/10.1016/j.indcrop.2015.07.003 DOI: https://doi.org/10.1016/j.indcrop.2015.07.003

Domingo-Fernández D, Gadiya Y, Preto AJ, Krettler CA, Mubeen S, Allen A, et al. Natural products have increased rates of clinical trial success throughout the drug development process. J Nat Prod. 2024;87(7):1844–51. https://doi.org/10.1021/acs.jnatprod.4c00581 DOI: https://doi.org/10.1021/acs.jnatprod.4c00581

de la Torre BG, Albericio F. The pharmaceutical industry in 2023: an analysis of FDA drug approvals from the perspective of molecules. Molecules. 2024;29(3):585. https://doi.org/10.3390/molecules29030585 DOI: https://doi.org/10.3390/molecules29030585

Pinela J, Barros L, Carvalho AM, Ferreira ICFR. Influence of the drying method in the antioxidant potential and chemical composition of four shrubby flowering plants from the tribe Genisteae (Fabaceae). Food Chem Toxicol. 2011;49(11):2983–9. https://doi.org/10.1016/j.fct.2011.07.054 DOI: https://doi.org/10.1016/j.fct.2011.07.054

Carreira-Casais A, Otero P, Garcia-Perez P, Garcia-Oliveira P, Pereira AG, Carpena M, et al. Benefits and drawbacks of ultrasound-assisted extraction for the recovery of bioactive compounds from marine algae. Int J Environ Res Public Health. 2021;18(17):9153. https://doi.org/10.3390/ijerph18179153 DOI: https://doi.org/10.3390/ijerph18179153

Kadam SU, Tiwari BK, O'Donnell CP. Application of novel extraction technologies for bioactives from marine algae. J Agric Food Chem. 2013;61(20):4667–75. https://doi.org/10.1021/jf400819p DOI: https://doi.org/10.1021/jf400819p

International Organization for Standardization. ISO 10993-5:2009. Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity. Geneva: International Organization for Standardization; 2009.

Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82(13):1107–12. https://doi.org/10.1093/jnci/82.13.1107 DOI: https://doi.org/10.1093/jnci/82.13.1107

Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112–6. https://doi.org/10.1038/nprot.2006.179 DOI: https://doi.org/10.1038/nprot.2006.179

Rodrigues ET, Nascimento SF, Moreno MJ, Oliveira PJ, Pardal MA. Rat cardiomyocyte H9c2(2-1)-based sulforhodamine B assay as a promising in vitro method to assess the biological component of effluent toxicity. J Environ Sci. 2020;96:163–70. https://doi.org/10.1016/j.jes.2020.04.029 DOI: https://doi.org/10.1016/j.jes.2020.04.029

Rodrigues ET, Pardal MA, Pereira E, Monteiro JF, Certal AC, Oliveira PJ. H9c2(2-1)-based sulforhodamine B assay as a possible alternative in vitro platform to investigate effluent and metals toxicity on fish. Chemosphere. 2021;275:130009. https://doi.org/10.1016/j.chemosphere.2021.130009 DOI: https://doi.org/10.1016/j.chemosphere.2021.130009

Rodrigues ET, Pereira E, Oliveira PJ, Pardal MA. The H9c2(2-1) cell-based sulforhodamine B assay is a non-animal alternative to evaluate municipal wastewater quality over time. Environ Monit Assess. 2023;195(11):1395.https://doi.org/10.1007/s10661-023-12017-8 DOI: https://doi.org/10.1007/s10661-023-12017-8

Varela AT, Neves RAF, Nascimento SM, Oliveira PJ, Pardal MA, Rodrigues ET, et al. Mitochondrial impairment and cytotoxicity effects induced by the marine epibenthic dinoflagellate Coolia malayensis. Environ Toxicol Pharmacol. 2020;77:103379. https://doi.org/10.1016/j.etap.2020.103379 DOI: https://doi.org/10.1016/j.etap.2020.103379

Indrayanto G, Putra GS, Suhud F. Validation of in-vitro bioassay methods: application in herbal drug research. Profiles Drug Subst Excip Relat Methodol. 2021;46:273–307. https://doi.org/10.1016/bs.podrm.2020.07.005 DOI: https://doi.org/10.1016/bs.podrm.2020.07.005

Iversen PW, Beck B, Chen YF, Dere W, Devanarayan V, Eastwood BJ, et al. HTS assay validation. In: Sittampalam GS, Coussens NP, Brimacombe K, et al., editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly and Company and National Center for Advancing Translational Sciences; 2012.

Guidance document on using cytotoxicity tests to estimate starting doses for acute oral systematic toxicity tests. OECD Series on Testing and Assessment. 2010.

Beck B, Chen YF, Dere W, Devanarayan V, Eastwood BJ, Farmen MW, et al. Assay operations for SAR support. In: Sittampalam GS, Coussens NP, Brimacombe K, et al., editors. Assay Guidance Manual. Bethesda (MD): Eli Lilly and Company and National Center for Advancing Translational Sciences; 2004. p. 1–7. PMID: 22553861.

Lahaye M, Robic A. Structure and functional properties of ulvan, a polysaccharide from green seaweeds. Biomacromolecules. 2007;8(6):1765–74. https://doi.org/10.1021/bm061185q DOI: https://doi.org/10.1021/bm061185q

Yaich H, Garna H, Besbes S, Barthélemy JP, Paquot M, Blecker C, et al. Impact of extraction procedures on the chemical, rheological and textural properties of ulvan from Ulva lactuca of Tunisia coast. Food Hydrocoll. 2014;40:53–63. https://doi.org/10.1016/j.foodhyd.2014.02.002 DOI: https://doi.org/10.1016/j.foodhyd.2014.02.002

Łabowska MB, Michalak I, Detyna J. Methods of extraction, physicochemical properties of alginates and their applications in biomedical field – a review. Open Chem. 2019;17(1):738–62. https://doi.org/10.1515/chem-2019-0077 DOI: https://doi.org/10.1515/chem-2019-0077

Cardozo KHM, Guaratini T, Barros MP, Falcão VR, Tonon AP, Lopes NP, et al. Metabolites from algae with economical impact. Comp Biochem Physiol C Toxicol Pharmacol. 2007;146(1–2):60–78. https://doi.org/10.1016/j.cbpc.2006.05.007 DOI: https://doi.org/10.1016/j.cbpc.2006.05.007

Cebrián-Lloret V, Martínez-Abad A, López-Rubio A, Martínez-Sanz M. Exploring alternative red seaweed species for the production of agar-based hydrogels for food applications. Food Hydrocoll. 2024;146:109177. https://doi.org/10.1016/j.foodhyd.2023.109177 DOI: https://doi.org/10.1016/j.foodhyd.2023.109177

Muñoz J, Culioli G, Köck M. Linear diterpenes from the marine brown alga Bifurcaria bifurcata: a chemical perspective. Phytochem Rev. 2013;12(3):407–24. https://doi.org/10.1007/s11101-012-9246-4 DOI: https://doi.org/10.1007/s11101-012-9246-4

Gallé JB, Attioua B, Kaiser M, Rusig AM, Lobstein A, Vonthron-Sénécheau C. Eleganolone, a diterpene from the French marine alga Bifurcaria bifurcata inhibits growth of the human pathogens Trypanosoma brucei and Plasmodium falciparum. Mar Drugs. 2013;11(3):599–610. https://doi.org/10.3390/md11030599 DOI: https://doi.org/10.3390/md11030599

Smyrniotopoulos V, Merten C, Kaiser M, Tasdemir D. Bifurcatriol, a new antiprotozoal acyclic diterpene from the brown alga Bifurcaria bifurcata. Mar Drugs. 2017;15(8):245. https://doi.org/10.3390/md15080245 DOI: https://doi.org/10.3390/md15080245

Pais ACS, Ramos B, Ricardo, Rosa D, Duarte MF, et al. High pressure extraction of bioactive diterpenes from the macroalgae Bifurcaria bifurcata: an efficient and environmentally friendly approach. RSC Adv. 2019;9(68):39893–903. https://doi.org/10.1039/C9RA06547D DOI: https://doi.org/10.1039/C9RA06547D

Pedro J, Cardoso C, Afonso F, Bandarra NM. Season affects three insufficiently studied seaweed species (Bifurcaria bifurcata, Codium sp., Ericaria selaginoides): bioactivity alterations. Appl Phycol. 2022;3(1):98–108. https://doi.org/10.1080/26388081.2022.2084454 DOI: https://doi.org/10.1080/26388081.2022.2084454

Silva J, Alves C, Freitas R, Martins A, Pinteus S, Ribeiro J, et al. Antioxidant and neuroprotective potential of the brown seaweed Bifurcaria bifurcata in an in vitro Parkinson's disease model. Mar Drugs. 2019;17(2):85. https://doi.org/10.3390/md17020085 DOI: https://doi.org/10.3390/md17020085

Silva J, Alves C, Pinteus S, Susano P, Simões M, Guedes M, et al. Disclosing the potential of eleganolone for Parkinson's disease therapeutics: neuroprotective and anti-inflammatory activities. Pharmacol Res. 2021;168:105589. https://doi.org/10.1016/j.phrs.2021.105589 DOI: https://doi.org/10.1016/j.phrs.2021.105589

Smyrniotopoulos V, Merten C, Firsova D, Fearnhead H, Tasdemir D. Oxygenated acyclic diterpenes with anticancer activity from the Irish brown seaweed Bifurcaria bifurcata. Mar Drugs. 2020;18(11):581. https://doi.org/10.3390/md18110581 DOI: https://doi.org/10.3390/md18110581

Agency for Toxic Substances and Disease Registry, US Environmental Protection Agency. Toxicological profile for n-hexane. US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry; 2025. https://www.atsdr.cdc.gov/toxprofiles/tp113.pdf

Ferreres F, Lopes G, Gil-Izquierdo A, Andrade P, Sousa C, Mouga T, et al. Phlorotannin extracts from Fucales characterized by HPLC-DAD-ESI-MSn: approaches to hyaluronidase inhibitory capacity and antioxidant properties. Mar Drugs. 2012;10(12):2766–81. https://doi.org/10.3390/md10122766 DOI: https://doi.org/10.3390/md10122766

Glombitza KW, Rosener HU, Müller D. Bifuhalol und diphlorethol aus Cystoseira tamariscifolia. Phytochemistry. 1975;14(4):1115–6. https://doi.org/10.1016/0031-9422(75)85198-3 DOI: https://doi.org/10.1016/0031-9422(75)85198-3

El Hattab M, Genta-Jouve G, Bouzidi N, Ortalo-Magné A, Hellio C, Maréchal JP, et al. Cystophloroketals A–E, unusual phloroglucinol-meroterpenoid hybrids from the brown alga Cystoseira tamariscifolia. J Nat Prod. 2015;78(7):1663–70. https://doi.org/10.1021/acs.jnatprod.5b00264 DOI: https://doi.org/10.1021/acs.jnatprod.5b00264

Rubiño S, Aymerich T, Peteiro C, Bover-Cid S, Hortós M. Antimicrobial potential of Ericaria selaginoides extracts against Listeria monocytogenes in “mató”, a Catalan fresh cheese. J Appl Phycol. 2023;35(2):949-59. https://doi.org/10.1007/s10811-023-02923-2 DOI: https://doi.org/10.1007/s10811-023-02923-2

de la Fuente G, Pinteus S, Silva J, Alves C, Pedrosa R. Antioxidant and antimicrobial potential of six Fucoids from the Mediterranean Sea and the Atlantic Ocean. J Sci Food Agric. 2022;102(12):5568–75. https://doi.org/10.1002/jsfa.11944 DOI: https://doi.org/10.1002/jsfa.11944

Martínez MA, Anadón A, Martínez M, Lopez-Torres B, Maximiliano JE, Martínez-Larrañaga MR, et al. P12-02 Ericaria selaginoides extract shows potential antioxidant activity in Caco-2 cells. Toxicol Lett. 2025;411–7. https://doi.org/10.1016/j.toxlet.2025.07.338 DOI: https://doi.org/10.1016/j.toxlet.2025.07.338

Zubia M, Fabre MS, Kerjean V, Lann KL, Stiger-Pouvreau V, Fauchon M, et al. Antioxidant and antitumoural activities of some Phaeophyta from Brittany coasts. Food Chem. 2009;116(3):693–701. https://doi.org/10.1016/j.foodchem.2009.03.025 DOI: https://doi.org/10.1016/j.foodchem.2009.03.025

Abudabbus A, Badmus JA, Shalaweh S, Bauer R, Hiss D. Effects of fucoidan and chemotherapeutic agent combinations on malignant and non-malignant breast cell lines. Curr Pharm Biotechnol. 2017;18(9):748–57. https://doi.org/10.2174/1389201018666171115115112 DOI: https://doi.org/10.2174/1389201018666171115115112

Article files

Additional Files

Publication details

Citation
Advance online
Language
EN
License
CC BY 4.0
Section
Research article

How to cite (Vancouver)

Rodrigues ET, Castanheira A, Pereira L, Pardal MA. Portuguese macroalgae as a source of bioactive compounds with selective anticancer activity against breast cancer cells. Biomol Biomed. 2026. https://doi.org/10.17305/bb.2026.13870

Share

Related articles